<h4>Context</h4>Adrenocorticotropic hormone (ACTH)-dependent Cushing syndrome (CS) is associated with a markedly increased risk of venous thromboembolism (VTE), yet thromboprophylaxis strategies remain inconsistent across clinical practice. This evidence concerns the gene POMC and venous thromboembolism.